Pacific Biosciences: Pressure Is Rising
Pacific Biosciences of California has seen a significant decline in its stock value, losing over 95% in the past five years. The company's recent Q1 revenue of $37.2 million fell short of expectations, prompting management to lower its full-year revenue guidance. This underperformance continues despite the volatility in the market and the company's efforts to recover.
- ▪Pacific Biosciences has lost over 95% of its value in five years.
- ▪The company's Q1 revenue of $37.2 million missed expectations.
- ▪Management has cut its full-year revenue guidance due to delayed consumables purchases.
Opening excerpt (first ~120 words) tap to expand
{"@context":"https://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https://seekingalpha.com/"},{"@type":"ListItem","position":2,"name":"Healthcare ","item":"https://seekingalpha.com/stock-ideas/healthcare"}]}{"@context":"https://schema.org","@type":"NewsArticle","mainEntityOfPage":{"@type":"WebPage","@id":"https://seekingalpha.com/article/4908659-pacific-biosciences-stock-pressure-is-rising"},"author":{"@type":"Person","name":"Bill Maurer","url":"https://seekingalpha.com/author/bill-maurer"},"publisher":{"@context":"http://schema.org","@type":"Organization","address":{"@type":"PostalAddress","streetAddress":"244 5th Ave","addressLocality":"New…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Seeking Alpha.
Discussion
0 commentsMore from Seeking Alpha
